Torigoe T - Search Results

1

Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer.

Nakayama Y, Yamauchi M, Minagawa N, Torigoe T, Izumi H, Kohno K, Yamaguchi K. Nakayama Y, et al. Among authors: torigoe t. Oncol Rep. 2012 May;27(5):1325-30. doi: 10.3892/or.2012.1640. Epub 2012 Jan 16. Oncol Rep. 2012. PMID: 22266811

2

P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA.

Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Itoh H, Kang D, Kohno K. Yoshida Y, et al. Among authors: torigoe t. Cancer Res. 2003 Jul 1;63(13):3729-34. Cancer Res. 2003. PMID: 12839966

3

The clinical usefulness of urinary N(1),N(12)-diacetylspermine (DiAcSpm) levels as a tumor marker in patients with colorectal cancer.

Nakayama Y, Torigoe T, Minagawa N, Yamaguchi K. Nakayama Y, et al. Among authors: torigoe t. Oncol Lett. 2012 May;3(5):970-974. doi: 10.3892/ol.2012.625. Epub 2012 Feb 29. Oncol Lett. 2012. PMID: 22783374 Free PMC article.

4

Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.

Nakayama Y, Torigoe T, Inoue Y, Minagawa N, Izumi H, Kohno K, Yamaguchi K. Nakayama Y, et al. Among authors: torigoe t. Exp Ther Med. 2012 Jan;3(1):25-30. doi: 10.3892/etm.2011.361. Epub 2011 Oct 7. Exp Ther Med. 2012. PMID: 22969839 Free PMC article.

5

Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells.

Yamauchi M, Nakayama Y, Minagawa N, Torigoe T, Shibao K, Yamaguchi K. Yamauchi M, et al. Among authors: torigoe t. Pancreas. 2014 Apr;43(3):405-10. doi: 10.1097/MPA.0000000000000049. Pancreas. 2014. PMID: 24622070

6

Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.

Katsuki T, Nakayama Y, Akiyama M, Sawatsubashi Y, Nagata J, Minagawa N, Torigoe T, Izumi H, Kohono K, Hirata K. Katsuki T, et al. Among authors: torigoe t. Anticancer Res. 2018 Jan;38(1):569-575. doi: 10.21873/anticanres.12261. Anticancer Res. 2018. PMID: 29277826

7

The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.

Abe Y, Nakayama Y, Katsuki T, Inoue Y, Minagawa N, Torigoe T, Higure A, Sako T, Nagata N, Hirata K. Abe Y, et al. Among authors: torigoe t. Asia Pac J Clin Oncol. 2019 Apr;15(2):e49-e55. doi: 10.1111/ajco.13077. Epub 2018 Sep 30. Asia Pac J Clin Oncol. 2019. PMID: 30270512

8

Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA.

Yoshida Y, Izumi H, Ise T, Uramoto H, Torigoe T, Ishiguchi H, Murakami T, Tanabe M, Nakayama Y, Itoh H, Kasai H, Kohno K. Yoshida Y, et al. Among authors: torigoe t. Biochem Biophys Res Commun. 2002 Jul 26;295(4):945-51. doi: 10.1016/s0006-291x(02)00757-x. Biochem Biophys Res Commun. 2002. PMID: 12127986

9

ZNF143 activates gene expression in response to DNA damage and binds to cisplatin-modified DNA.

Ishiguchi H, Izumi H, Torigoe T, Yoshida Y, Kubota H, Tsuji S, Kohno K. Ishiguchi H, et al. Among authors: torigoe t. Int J Cancer. 2004 Oct 10;111(6):900-9. doi: 10.1002/ijc.20358. Int J Cancer. 2004. PMID: 15300802

10

Cisplatin resistance and transcription factors.

Torigoe T, Izumi H, Ishiguchi H, Yoshida Y, Tanabe M, Yoshida T, Igarashi T, Niina I, Wakasugi T, Imaizumi T, Momii Y, Kuwano M, Kohno K. Torigoe T, et al. Curr Med Chem Anticancer Agents. 2005 Jan;5(1):15-27. doi: 10.2174/1568011053352587. Curr Med Chem Anticancer Agents. 2005. PMID: 15720258 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters